PharmaShots | Incisive News in 3 Shots

Subscribe Now

Accelerated

Janssen Reports CHMP's Acceptance for Accelerated Assessment of Cilta-cel's MAA to Treat Patients with Heavily Pretreated Multiple Myeloma

Janssen Reports CHMP's Acceptance for Accelerated Assessment of Cilta-cel's MAA to Treat Patients with Heavily Pretreated Multiple...

February 2, 2021

Pharma Mar's Zepzelca (lurbinectedin) Receives the US FDA's Accelerated Approval for Adult Patients with Metastatic Small Cell Lung Cancer (SCLC)

Pharma Mar's Zepzelca (lurbinectedin) Receives the US FDA's Accelerated Approval for Adult Patients with Metastatic Small Cell Lun...

June 15, 2020

Immunomedics' Trodelvy Receives the US FDA's Accelerated Approval for 2L Patients with Metastatic Triple-Negative Breast Cancer (TNBC)

Immunomedics' Trodelvy Receives the US FDA's Accelerated Approval for 2L Patients with Metastatic Triple-Negative Breast Cancer (T...

April 22, 2020

$Roche's Polivy (polatuzumab vedotin-piiq) Combination Therapy Receives FDA's Accelerated Approval for Relapsed/Refractory Lymphoma$

Roche's Polivy (polatuzumab vedotin-piiq) Combination Therapy Receives FDA's Accelerated Approval for Relapsed/Refractory Lymphoma

June 11, 2019

Roche's Tecentriq + Abraxane Receive FDA's Accelerated Approval for mTNBC

Roche's Tecentriq + Abraxane Receive FDA's Accelerated Approval for mTNBC

March 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us